After stopping Farxiga trial early, AstraZeneca declares success in CKD treatment
Back in March, AstraZeneca announced plans to halt a Phase III trial for its Farxiga drug ahead of schedule after seeing “overwhelming efficacy” in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.